Doxorubicin Impurity 6(69429-21-6)
- Name: Doxorubicin Impurity 6
- Synonyms:Doxorubicin Impurity 6;(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy>(7S,9S)-7-<-9-carboxy-7,8,9,10-tetrahydro-6,9,11-trihydroxy-4-methoxy-5,12-naphthacenedione;2-Naphthacenecarboxylic acid, 4-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-, (2S,4S)-;(2S,4S)-4-(((4S,5S,6R)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-2-carboxylicacid;(7S,9S)-7-<(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy>-9-carboxy-7,8,9,10-tetrahydro-6,9,11-trihydroxy-4-methoxy-5,12-naphthacenedione;(2S,4S)-4-(((2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-2-carboxylic acid (Doxorubicin Impurity)
- Molecular Formula:C26H27NO11
- Molecular Weight:529.49
- CAS Registry Number:69429-21-6
- EINECS:
- Melting Point:815.3±65.0 °C(Predicted)
- Water Solubility:
Other Product
- 69389-17-9/1-(5-methyl-1,3,4-thiadiazol-2-yl)piperazine dihydrochloride
- 69389-19-1/1-(3-methyl-1,2,4-thiadiazol-5-yl)piperazine dihydrochloride
- 69389-20-4/1-(1,2,4-thiadiazol-5-yl)piperazine dihydrochloride
- 69389-21-5/1-(1H-1,2,4-triazol-3-yl)piperazine dihydrochloride
- 6939-62-4/Silicate(2-), hexafluoro-, dihydrogen, compd. with m-aminophenol (1:2) (8CI)
- 69400-45-9/Osmate(2-), hexachloro-, (OC-6-11)-, dihydrogen, compd. with naphtho[1,2-d]thiazol-2-amine (1:2) (9CI)
- 69400-46-0/Platinate(2-), hexachloro-, (OC-6-11)-, dihydrogen, compd. with 4-(chloromethyl)-2-thiazolamine (1:2) (9CI)
- 69403-61-8/1-(2-Ethoxy-2-oxoethyl)-2,4,6-trimethylpyridin-1-ium tetrafluoroboranuide
- 69404-43-9/Phosphonic acid, P-(bromomethyl)-, dimethyl ester
- 69404-50-8/2-(2'-Phosphonoethoxy)ethylphosphonic acid
- 6940-55-0/4-Chloro2,5-Dimethoxynitrobenzene
- 69408-85-1/LysoFP-NH2
- 69410-25-9/2-(4-Fluoro-phenylamino)-3-methyl-butyric acid
- 69413-22-5/3-methyl-1-(3-nitrobenzoyl)-1H-pyrazole
- 694-13-3/Pyridine, 2-fluoro-, compd. with iodine chloride (ICl) (1:1) (8CI,9CI)
- 694-15-5/Boron, trifluoro(tetrahydrothiophene)-, (T-4)- (9CI)
- 69416-77-9/1-(but-3-en-1-yl)azetidine
- 694-19-9/1,2-Cyclopropanedione, 3,3-dimethyl-
- 69426-59-1/Platinum, dichlorobis(naphtho[1,2-d]thiazol-2-amine-κN2)-, (SP-4-2)- (9CI)
- 69429-21-6/Doxorubicin Impurity 6
- 69442-32-6/5-ethyl-2-formylthiophene-3-carboxylic acid
- 694430-32-5/Benzeneacetonitrile, α-amino-2-(trifluoromethyl)-
- 694432-23-0/3-Pyrrolidinecarboxylicacid,1-ethenyl-2-oxo-(9CI)
- 694439-60-6/[1-(Sulfanylmethyl)cyclohexyl]methanol
- 694443-29-3/methyl 2-(2,3-dihydro-1,4-benzodioxin-7-yl-methylsulfonyl-amino)ethanoate
- 694443-51-1/1-Ethoxy-4-[(4-nitrobenzyl)oxy]benzene
- 694448-41-4/N-(3,4-dimethoxyphenyl)-3-(4-oxo-3(4H)-quinazolinyl)propanamide
- 694454-06-3/MFCD03999841
- 694458-60-1/2-methyl-1-[(2,4,5-trimethylphenyl)sulfonyl]-1H-benzimidazole
- 694460-45-2/2-(2-chloro-4-formyl-6-methoxyphenoxy)-N-(3-methylphenyl)acetamide